No impact of tumor necrosis-factor antagonists on the joint manifestations of sarcoidosis

OBJECTIVE: The use of anti-tumor necrosis factor (TNF) agents to treat joint manifestations of sarcoidosis has not been described. We evaluated the efficacy and safety of three such biologics in patients with these symptoms refractory to conventional therapy (nonsteroidal anti-inflammatory drugs, co...

Descripción completa

Detalles Bibliográficos
Autores principales: Banse, Christopher, Bisson-Vaivre, Aurélia, Kozyreff-Meurice, Marie, Vittecoq, Olivier, Goëb, Vincent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3724565/
https://www.ncbi.nlm.nih.gov/pubmed/23901289
http://dx.doi.org/10.2147/IJGM.S44542

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3724565/
https://www.ncbi.nlm.nih.gov/pubmed/23901289
http://dx.doi.org/10.2147/IJGM.S44542

Ejemplares similares